Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma.

Anticancer research - 1 Sept 2016

Bur Hamid, Haapasaari Kirsi-Maria, Turpeenniemi-Hujanen Taina, Kuittinen Outi, Auvinen Päivi, Marin Katja, Soini Ylermi, Karihtala Peeter

Abstract excerpt

BACKGROUND: Epigenetic regulators, including Jumonji domain 2 (JMJD2/KDM4) proteins are involved in post-translational modification of histone demethylation and have a major role in carcinogenesis of many solid tumors. MATERIALS AND METHODS: We assessed immunohistochemically the expression of lysine (K)-specific demethylase 4 (KDM4)A, KDM4B and KDM4D in tumors from 91 patients of adriamycin, bleomycin,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bleomycin
Share to Dacarbazine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Doxorubicin

Share to Hodgkin Disease

Share to Jumonji Domain-Containing Histone Demethylases

Share to Neoplasm Recurrence, Local

Share to Vinblastine

Source

Identifiers

PMID: 27630312
DOI: 10.21873/anticanres.11020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma.PMID 27630312Read ↗

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict OutcomeSemantic proximity Read ↗

Gene expression profiling defines molecular subtypes of classical Hodgkin's diseaseSemantic proximity Read ↗

A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4Semantic proximity Read ↗

Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a ActivitySemantic proximity Read ↗

Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.Semantic proximity Read ↗

Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphomaSemantic proximity Read ↗

The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's LymphomaSemantic proximity Read ↗

Three-dimensional Telomere Signatures of Hodgkin- and Reed-Sternberg Cells at Diagnosis Identify Patients with Poor Response to Conventional ChemotherapySemantic proximity Read ↗

Molecular analysis of Hodgkin's disease with abundant Reed-Sternberg cells.Semantic proximity Read ↗

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.